| Name | Title | Contact Details |
|---|
Creative Health Care Management is a Hopkins, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
River Garden Hebrew Home is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. River Garden Hebrew Home is based in Jacksonville, FL. You can find more information on River Garden Hebrew Home at www.rivergarden.org
Our passion for helping older adults is not something that has developed over night. With 26 years of commitment, our family owned organization has proven to excel in giving loving care to those in need of assistance. It is our mission to provide compassionate care to seniors in a real home environment. We feel that a smaller setting is most ideal for one to receive individual attention and continue establishing meaningful relationships between peers. Our goal is focused on improving the physical and emotional well-being of our residents to help maintain their independence. We are committed to upholding the highest standards of care as we strive to improve quality of life.
Suncoast Communities Blood Bank is a Sarasota, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.